Native dynamics and allosteric responses in PTP1B probed by high-resolution HDX-MS

Protein tyrosine phosphatase 1B (PTP1B) is a validated therapeutic target for obesity, diabetes, and certain types of cancer. In particular, allosteric inhibitors hold potential for therapeutic use, but an incomplete understanding of conformational dynamics and allostery in this protein has hindered their development. Here, we interrogate solution dynamics and allosteric responses in PTP1B using high-resolution hydrogen-deuterium exchange mass spectrometry (HDX-MS), an emerging and powerful biophysical technique. Using HDX-MS, we obtain a detailed map of the solution dynamics of apo PTP1B, revealing several flexible loops interspersed among more constrained and rigid regions within the protein structure, as well as variability between different residues within the allosteric α7 helix. We demonstrate that our HDX dynamics data obtained in solution adds value to predictions of dynamics derived from a pseudo-ensemble constructed from ∼200 crystal structures of PTP1B. Furthermore, we report HDX-MS maps for PTP1B with active-site vs. allosteric small-molecule inhibitors. These maps reveal dramatic and widespread effects on protein dynamics relative to the apo form, including changes to dynamics in locations distal (>35 Å) from the respective ligand binding sites. These results help shed light on the allosteric nature of PTP1B and the surprisingly far-reaching consequences of inhibitor binding in this important protein. Overall, our work showcases the potential of HDX-MS for elucidating protein conformational dynamics and allosteric effects of small-molecule ligands, and highlights the potential of integrating HDX-MS alongside other complementary methods to guide the development of new therapeutics.

[1]  S. Marqusee,et al.  Ligand-specific changes in conformational flexibility mediate long-range allostery in the lac repressor , 2023, Nature Communications.

[2]  K. Lindorff-Larsen,et al.  Conserved conformational dynamics determine enzyme activity , 2022, Science advances.

[3]  J. Dupret,et al.  Human Protein Tyrosine Phosphatase 1B (PTP1B): From Structure to Clinical Inhibitor Perspectives , 2022, International journal of molecular sciences.

[4]  Saulo H. P. de Oliveira,et al.  Ligand binding remodels protein side chain conformational heterogeneity , 2021, bioRxiv.

[5]  D. Herschlag,et al.  Assessment of enzyme active site positioning and tests of catalytic mechanisms through X-ray–derived conformational ensembles , 2019, Proceedings of the National Academy of Sciences.

[6]  Frank von Delft,et al.  An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering , 2018, eLife.

[7]  Gilles Gasser,et al.  A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models , 2017, The Journal of Biological Chemistry.

[8]  Sebastian Kelm,et al.  A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density , 2017, Nature Communications.

[9]  K. Lindorff-Larsen,et al.  Conformational Rigidity and Protein Dynamics at Distinct Timescales Regulate PTP1B Activity and Allostery. , 2017, Molecular cell.

[10]  Wei Wang,et al.  Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes. , 2016, Future medicinal chemistry.

[11]  Modesto Orozco,et al.  Correlated motions are a fundamental property of β-sheets , 2014, Nature Communications.

[12]  Daniel H. Miller,et al.  Targeting the disordered C-terminus of PTP1B with an allosteric inhibitor , 2014, Nature chemical biology.

[13]  E. Purisima,et al.  Allosteric Noncompetitive Small Molecule Selective Inhibitors of CD45 Tyrosine Phosphatase Suppress T-Cell Receptor Signals and Inflammation In Vivo , 2014, Molecular Pharmacology.

[14]  Nan Yan,et al.  Conformational Motions Regulate Phosphoryl Transfer in Related Protein Tyrosine Phosphatases , 2013, Science.

[15]  Sean J. Johnson,et al.  The molecular details of WPD-loop movement differ in the protein-tyrosine phosphatases YopH and PTP1B. , 2012, Archives of biochemistry and biophysics.

[16]  Ivet Bahar,et al.  ProDy: Protein Dynamics Inferred from Theory and Experiments , 2011, Bioinform..

[17]  Burak Alakent,et al.  Alpha7 Helix Plays an Important Role in the Conformational Stability of PTP1B , 2011, Journal of biomolecular structure & dynamics.

[18]  M. DePristo,et al.  Relation between native ensembles and experimental structures of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Erlanson,et al.  Allosteric inhibition of PTP1B activity by selective modification of a non-active site cysteine residue. , 2005, Biochemistry.

[20]  J. Kastrup,et al.  Water-molecule network and active-site flexibility of apo protein tyrosine phosphatase 1B. , 2004, Acta crystallographica. Section D, Biological crystallography.

[21]  Wang Shen,et al.  Allosteric inhibition of protein tyrosine phosphatase 1B , 2004, Nature Structural &Molecular Biology.

[22]  D. Lawrence,et al.  Probing the Molecular Basis for Potent and Selective Protein-tyrosine Phosphatase 1B Inhibition* , 2002, The Journal of Biological Chemistry.

[23]  P G Drake,et al.  Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains , 2001, Molecular and Cellular Biology.

[24]  Ole Hvilsted Olsen,et al.  Structure-based Design of a Low Molecular Weight, Nonphosphorus, Nonpeptide, and Highly Selective Inhibitor of Protein-tyrosine Phosphatase 1B* , 2000, The Journal of Biological Chemistry.

[25]  K. Guan,et al.  Altering the Nucleophile Specificity of a Protein-tyrosine Phosphatase-catalyzed Reaction , 1998, The Journal of Biological Chemistry.

[26]  D S Lawrence,et al.  Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Dixon,et al.  Dissecting the catalytic mechanism of protein-tyrosine phosphatases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Tautz,et al.  Protein tyrosine phosphatases: structure, function, and implication in human disease. , 2013, Methods in molecular biology.

[29]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..